5,434 results on '"Gordon AS"'
Search Results
2. Dissection of single-cell landscapes for the development of chimeric antigen receptor T cells in Hodgkin lymphoma
3. Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition
4. A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels
5. Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001
6. Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure
7. Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study
8. Optimizing the value of lenalidomide maintenance by extended genetic profiling: an analysis of 556 patients in the Myeloma XI trial
9. Disruption of dNTP homeostasis by ribonucleotide reductase hyperactivation overcomes AML differentiation blockade
10. The histone lysine acetyltransferase HBO1 (KAT7) regulates hematopoietic stem cell quiescence and self-renewal
11. Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONE
12. Molecular classification improves risk assessment in adult BCR-ABL1–negative B-ALL
13. A rapid genotyping panel for detection of primary central nervous system lymphoma
14. Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma
15. Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma
16. Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells
17. Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set
18. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
19. Thrombosis in patients with myeloma treated in the Myeloma IX and Myeloma XI phase 3 randomized controlled trials
20. Integrative analysis of spontaneous CLL regression highlights genetic and microenvironmental interdependency in CLL
21. Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism
22. PHF6 regulates hematopoietic stem and progenitor cells and its loss synergizes with expression of TLX3 to cause leukemia
23. Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition
24. Characterization of reverse-engineered anti-PF4 stereotypic antibodies derived from serum of patients with VITT
25. RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature
26. North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies
27. Extracellular galectins as controllers of cytokines in hematological cancer
28. Disruption Of PML Nuclear Bodies Cooperates In The Pathogenesis Of Acute Promyelocytic Leukemia
29. Rapid tumor DNA analysis of cerebrospinal fluid accelerates treatment of central nervous system lymphoma
30. KB-Lanra 1001: A Phase 1b/2 Study of Safety, PK, PD, and Preliminary Efficacy of the Selective SYK Inhibitor Lanraplenib in Combination with the FLT3 Inhibitor Gilteritinib in FLT3-Mutated R/R AML
31. Treatment of Critical Bleeding Events in Patients with Immune Thrombocytopenia: A Systematic Review
32. A critical epithelial survival axis regulated by MCL-1 maintains thymic function in mice
33. Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma
34. Therapeutic potential of SGN-CD19B, a PBD-based anti-CD19 drug conjugate, for treatment of B-cell malignancies
35. Impact of a Validated Composite Comorbidity Score on Outcomes in Patients Treated with CAR T-Cell Therapy for Diffuse Large B Cell Lymphoma (DLBCL): A Multicenter Real-World Evidence (RWE) Study
36. Global Treatment Standard in Multiple Myeloma Remains Elusive: Updated Results from the INSIGHT MM Global, Prospective, Observational Study
37. Vaccine-induced immune thrombotic thrombocytopenia is mediated by a stereotyped clonotypic antibody
38. Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy
39. Modeling altered T-cell development with induced pluripotent stem cells from patients with RAG1-dependent immune deficiencies
40. Targetable genetic features of primary testicular and primary central nervous system lymphomas
41. Transfusion of fresher vs older red blood cells in hospitalized patients: a systematic review and meta-analysis
42. Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)
43. Impact of a Validated Composite Comorbidity Score on Outcomes in Patients Treated with CAR T-Cell Therapy for Diffuse Large B Cell Lymphoma (DLBCL): A Multicenter Real-World Evidence (RWE) Study
44. Depletion of the chromatin remodeler CHD4 sensitizes AML blasts to genotoxic agents and reduces tumor formation
45. Microenvironmental interleukin-6 suppresses toll-like receptor signaling in human leukemia cells through miR-17/19A
46. B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality
47. IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells
48. Consensus Cachexia Criteria Are Independently Linked to Progression Free and Overall Survival in Multi-Site Analysis of Patients with Aggressive B-Cell Lymphomas Treated with CAR T-Cell Therapy
49. Safety and Pharmacokinetics of Subcutaneous Blinatumomab (SC blinatumomab) for the Treatment of Adults with Relapsed or Refractory B Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL); Results from a Phase 1b Study
50. Co-Occurrence of High-Risk Lesions Is a Consistent Predictor of Ultra-High Risk Multiple Myeloma in Newly Diagnosed and Relapsed/Refractory Patients - Meta-Analysis of 5,808 Trial Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.